Protein Polymer Technologies to Present At BiomaterialsOf The Future Conference

    SAN DIEGO, Nov. 13, 1997 -- Protein Polymer Technologies, Inc. (Nasdaq: PPTI), will present at the Medical Data International's "Biomaterials of the Future" Conference on Tuesday, November 18, 1997 at the ANA Hotel in San Francisco.  This two-day conference brings together experts and emerging medical companies to discuss latest advances in the development of new biomaterial technologies in the cardiovascular, musculoskeletal and surgical marketplace.
    Joseph Cappello, Ph.D., Vice President of Research & Development and Chief Technical Officer will discuss latest achievements with PPTI's development programs, including new ProLastin(TM) hydrogels targeted for the treatment of incontinence.  Other targeted applications include tissue adhesives and sealants, wound healing, contact lens coatings, surgical adhesion barriers and drug delivery vehicles.
    Protein Polymer Technologies, Inc., a San Diego-based biotechnology company, has a technology platform that allows the creation of a number of different classes of biocompatible polymers that enable cell growth, promote the regeneration of tissue, bond to synthetic surfaces and resorb into tissue at controlled rates.  PPTI's lead program, a new generation of surgical adhesives and sealants to replace or augment the use of sutures and staples, is being developed in collaboration with Ethicon, a Johnson & Johnson company.